PPD® Biotech is a Phase I-IV contract research organization (CRO) service provider devoted to biotech and small to midsize pharma companies.
Extensive knowledge of hematology and oncology research, vast capabilities and experience with feasibility studies and a large investigator network.
As clinical trial investigators, physicians play an integral role in the development of life-changing medicines.
View all of PPD's news releases.
As the leading CRO in rare disease research, we are excited to share our insights with you at WODC 2019. We deploy flexible, patient-centric study designs to drive success in patient recruitment and retention. Visit us at booth #401, or set up a customized meeting with one of our experts. We look forward to meeting you.
NATIONAL HARBOR, MARYLAND
Wednesday through Friday, 10-12 April 2019
Please fill out the following form to request a meeting that will be customized to meet your needs.
Patient-Focused Rare Disease Clinical Trial Protocols—Patient-Centered Outcomes and Beyond
Thursday, 11 April, 12:40 p.m. (EDT)
Margaret Vernon, VP & General Manager, Patient-Centered Research, Evidera
Kevin Marsh, PhD, Executive Director, Commercial Strategy & New Product Development, Patient-Centered Research, Evidera
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.